LLY News

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

Best Weight Loss Pills for 2026: FDA Approves First Oral GLP-1 and What It Means for Patients

Rejuvacare Ozempatch Ingredients Investigated: 2026 Consumer Analysis Examines Herbal Patch Formulation Disclosures

Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets

SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies

Chai Discovery Announces Collaboration with Eli Lilly and Company to Accelerate Biologics Discovery

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

Ventyx Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Ventyx Biosciences, Inc. - VTYX